NEW YORK, NY / ACCESSWIRE / June 15, 2020 -/Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.
GSX Shareholders Click Here: https://www.zlk.com/pslra-1/gsx-techedu-inc-loss-form?prid=7343&wire=1
GRPN Shareholders Click Here: https://www.zlk.com/pslra-1/groupon-inc-loss-form?prid=7343&wire=1
SRNE Shareholders Click Here: https://www.zlk.com/pslra-1/sorrento-therapeutics-inc-information-request-form?prid=7343&wire=1
* ADDITIONAL INFORMATION BELOW *
GSX Techedu Inc. (NYSE: GSX)
GSX Lawsuit on behalf of: investors who purchased June 6, 2019 - April 13, 2020
Lead Plaintiff Deadline : June 16, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/gsx-techedu-inc-loss-form?prid=7343&wire=1
According to the filed complaint, during the class period, GSX Techedu Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) GSX overstated its profitability, revenue, student enrollment figures, teacher qualifications, and teacher selection process; (ii) the foregoing, once revealed, was foreseeably likely to have a material negative impact on the Company's financial results; and (iii) as a result, the Company's public statements were materially false and misleading at all relevant times.
Groupon, Inc. (NASDAQ: GRPN)
GRPN Lawsuit on behalf of: investors who purchased November 4, 2019 - February 18, 2020
Lead Plaintiff Deadline : June 29, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/groupon-inc-loss-form?prid=7343&wire=1
According to the filed complaint, during the class period, Groupon, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was experiencing fewer customer engagements in its Goods category; (2) Groupon relied on its Goods category to drive its sales, especially during the holiday season; (3) as a result of the foregoing, the Company was likely to experience reduced sales; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Sorrento Therapeutics, Inc. (NASDAQ: SRNE)
SRNE Lawsuit on behalf of: investors who purchased May 15, 2020 - May 22, 2020
Lead Plaintiff Deadline : July 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/sorrento-therapeutics-inc-information-request-form?prid=7343&wire=1
According to the filed complaint, during the class period, Sorrento Therapeutics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (i) the Company's initial finding of "100% inhibition" in an in vitro virus infection will not necessarily translate to to success or safety in vivo, or in person; (ii) the Company's finding was not a "cure" for COVID-19; and (ii) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
[email protected]
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com
SOURCE: Levi & Korsinsky, LLP